Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
STTKthis companyShattuck Labs, Inc.	$4.87	-5.21×	3.08×	253.99×	-4.48×	-88.5%	-195.1%	-5150.8%	-4880.9%	-59.2%	-60.7%	-15.7%	0.03×	1.15×	0×	11.7×	0.0%	2	31.03	2	C
BDTXBlack Diamond Therapeutics, Inc.	$1.84	6.23×	1.23×	1.97×	5.99×	520.8%	99.5%	28.4%	32.0%	19.9%	15.2%	21.4%	0.17×	-0.1×	0×	8.42×	0.0%	1	-3.44	3	B-
CBIOCrescent Biopharma, Inc.	$14.30	-0.8×	0.61×	11.39×	0.59×	61.0%	100.0%	-1407.5%	-1419.6%	-75.8%	-74.6%	-117.0%	0.01×	1.41×	-69.85×	6.56×	0.0%	3	11.24	2	C+
CVMCEL-SCI Corporation	$1.48	-1.47×	2.34×	0×	-1.71×	-84.4%	0.0%	0.0%	0.0%	-159.2%	-97.4%	-46.0%	0.59×	0.08×	-38.23×	2.26×	0.0%	2	-38.36	2	C
FTHFaeth Therapeutics, Inc.	$11.18	-0.64×	0.72×	0×	-0.3×	-73.2%	0.0%	0.0%	0.0%	-113.4%	-110.9%	-152.2%	0.08×	0.34×	-696.5×	5.06×	0.0%	3	20.19	3	B-
INDPIndaptus Therapeutics, Inc.	$3.35	-0.13×	0.89×	0×	0.27×	137.0%	0.0%	0.0%	0.0%	-661.5%	-629.3%	-527.3%	0×	0.41×	0×	1.51×	0.0%	2	373.3	2	C
Peer median	—	-0.64×	0.89×	0×	0.27×	61.0%	0.0%	0.0%	0.0%	-113.4%	-97.4%	-117.0%	0.08×	0.34×	-38.23×	5.06×	0.0%	2	11.24	2	—